valproic acid has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behl, B; Gross, G; Hofmann, HP; Höger, T; Lehmann, H; Lemaire, HG; Löscher, W; Lubisch, W; Seemann, D; Teschendorf, HJ | 1 |
1 other study(ies) available for valproic acid and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
| Article | Year |
|---|---|
A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
Topics: Amygdala; Animals; Anticonvulsants; Binding, Competitive; Cell Death; Electroshock; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; Female; GABA Agents; Kindling, Neurologic; Kinetics; Male; Mice; Mice, Inbred Strains; Neurons; Phenylurea Compounds; Pyrroles; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Temporal Lobe; Valproic Acid | 1999 |